当前位置: 首页 > 期刊 > 《中国医药导报》 > 2016年第29期
编号:1597862
慢性乙型肝炎后肝硬化中西医治疗研究进展
http://www.100md.com 2016年12月27日 中国医药导报 2016年第29期
中医,中西医结合
     冯因克 刘亚敏 陈启龙

    [摘要] 慢性乙型肝炎后肝硬化是乙型病毒性肝炎发展到终末期的常见表现,后期可因出现肝性脑病、原发性肝癌、感染等严重并发症而导致死亡,临床治疗一直收效甚微。目前,尽管西医抗病毒依然是乙肝后肝硬化治疗的首选,但中医辨证治疗乙肝后肝硬化也具有独特作用。近年来,中医药在临床辨证及对症治疗乙肝后肝硬化已经有了大量的探索。本文从中医、西医及中西医结合三个方面综述了乙肝后肝硬化治疗的研究进展,并展望了精准医疗在乙肝后肝硬化个性化治疗上的应用前景,以期为乙肝后肝硬化精确治疗的发展提供参考。

    [关键词] 乙肝后肝硬化;中医;西医;中西医结合;精准医疗

    [中图分类号] R575.2 [文献标识码] A [文章编号] 1674-4721(2016)10(b)-0028-04

    [Abstract] Cirrhosis due to hepatitis B is a common pathological consequence of chronic hepatitis B in final stage, which might lead to the emergence of hepatic encephalopathy, primary liver cancer, infection and other serious complications and death. However, the therapeutic efficacy of cirrhosis due to hepatitis B is challenging in clinical treatment. Presently, the western medicine is still the first choice for the treatment of hepatitis B cirrhosis, but the traditional Chinese medicine has a special therapeutic efficacy for the treatment of cirrhosis due to hepatitis B. In past decades, traditional Chinese medicine causing prospect for cirrhosis due to hepatitis B treatment. This paper reviews the development of cirrhosis due to hepatitis B treatments from traditional Chinese medicine ......

您现在查看是摘要页,全文长 13738 字符